RELATED: Trump says GLP-1 weight-loss drugs coming at $50 for Medicare patients The Trump administration had said that coverage of the drugs for obesity will expand to Medicare patients starting next year, but Trump announced May 2 that Zepbound and Wegovy would be available to Medicare patients for $50 a month starting July 1
Please review all associated safety details and consult your provider for personalized advice
The tradeoff is that patients need to be prepared for dose escalation, possible side effects, and the importance of hydration, protein intake, bowel regularity, and consistent follow-up
2014;10(1 Suppl):S2632
People pursuing GLP-1s shouldnt be afraid to speak with their doctors about the option of compounded products, and they shouldnt be afraid to ask telehealth companies, clinics, or med spas questions like: Are your products compounded
This is a medical emergency requiring immediate 911 activation